As of 2024-09-15, the EV/EBITDA ratio of Flexion Therapeutics Inc (FLXN) is -7.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLXN's latest enterprise value is 564.21 mil USD. FLXN's TTM EBITDA according to its financial statements is -78.25 mil USD. Dividing these 2 quantities gives us the above FLXN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 15.9x | 13.0x |
| Forward P/E multiples | 16.4x - 21.5x | 18.9x |
| Fair Price | (28.25) - (27.42) | (27.61) |
| Upside | -409.7% - -400.7% | -402.7% |
| Date | EV/EBITDA |